General Introduction 19 1 34. World Health Organization (WHO). A global brief on hypertension. http://apps.who.int/iris/ bitstream/10665/79059/1/WHO_DCO_WHD_2013.2_eng.pdf. Published 2013. Accessed August 3, 2017. 35. Houston MC, Harper KJ. Potassium, magnesium, and calcium: their role in both the cause and treatment of hypertension. J Clin Hypertens (Greenwich). 2008;10(7 Suppl 2):3-11. 36. Forman JP, Stampfer MJ, Curhan GC. Diet and lifestyle risk factors associated with incident hypertension in women. JAMA - J Am Med Assoc. 2009. doi:10.1001/jama.2009.1060 37. Kieneker LM, Gansevoort RT, Mukamal KJ, et al. Urinary potassium excretion and risk of developing hypertension: the prevention of renal and vascular end-stage disease study. Hypertens (Dallas,Tex 1979).2014;64(4):769-776.doi:10.1161/HYPERTENSIONAHA.114.03750 38. Joosten MM, Gansevoort RT, Mukamal KJ, et al. Urinary magnesium excretion and risk of hypertension: the prevention of renal and vascular end-stage disease study. Hypertens (Dallas, Tex 1979). 2013;61(6):1161-1167. doi:10.1161/HYPERTENSIONAHA.113.01333 39. Kass L, Weekes J, Carpenter L. Effect of magnesium supplementation on blood pressure: a meta-analysis. Eur J Clin Nutr. 2012;66(4):411-418. doi:10.1038/ejcn.2012.4 40. Jee SH, Miller ER 3rd, Guallar E, Singh VK, Appel LJ, Klag MJ. The effect of magnesium supplementation on blood pressure: a meta-analysis of randomized clinical trials. Am J Hypertens. 2002;15(8):691-696. 41. Mattace-Raso FUS, van der Cammen TJM, Hofman A, et al. Arterial Stiffness and Risk of Coronary Heart Disease and Stroke. Circulation. 2006;113(5):657-663. doi:10.1161/ CIRCULATIONAHA.105.555235 42. Tanaka H.Various Indices of Arterial Stiffness: Are They Closely Related or Distinctly Different? Pulse. 2017. doi:10.1159/000461594 43. Laurent S, Cockcroft J, Van Bortel L, et al. Expert consensus document on arterial stiffness: methodological issues and clinical applications. Eur Heart J. 2006;27(21):2588-2605. doi:10.1093/eurheartj/ehl254 44. Tesauro M, Mauriello A, Rovella V, et al. Arterial ageing: from endothelial dysfunction to vascular calcification. J Intern Med. 2017;281(5):471-482. doi:10.1111/joim.12605 45. Angoff R, Mosarla RC, Tsao CW. Aortic Stiffness: Epidemiology, Risk Factors, and Relevant Biomarkers. Front Cardiovasc Med. 2021;8. doi:10.3389/fcvm.2021.709396 46. ter Braake AD, Tinnemans PT, Shanahan CM, Hoenderop JGJ, de Baaij JHF. Magnesium prevents vascular calcification in vitro by inhibition of hydroxyapatite crystal formation. Sci Rep. 2018;8(1):2069. doi:10.1038/s41598-018-20241-3 47. ter Braake AD, Smit AE, Bos C, et al. Magnesium prevents vascular calcification in Klotho deficiency. Kidney Int. 2020. doi:10.1016/j.kint.2019.09.034 48. Steptoe A, Kivimäki M. Stress and cardiovascular disease. Nat Rev Cardiol. 2012. doi:10.1038/ nrcardio.2012.45 49. Tomlinson JW, Walker EA, Bujalska IJ, et al. 11β-Hydroxysteroid Dehydrogenase Type 1: A Tissue-Specific Regulator of Glucocorticoid Response. Endocr Rev. 2004;25(5):831-866. doi:10.1210/er.2003-0031 50. Edwards CR, Stewart PM, Burt D, et al. Localisation of 11 beta-hydroxysteroid dehydrogenase- -tissue specific protector of the mineralocorticoid receptor. Lancet (London, England). 1988;2(8618):986-989. doi:10.1016/s0140-6736(88)90742-8
RkJQdWJsaXNoZXIy MTk4NDMw